Literature DB >> 19220836

T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease.

C Lambers1, S Hacker, M Posch, K Hoetzenecker, A Pollreisz, M Lichtenauer, W Klepetko, H Jan Ankersmit.   

Abstract

Pathogenetic mechanisms leading to chronic obstructive pulmonary disease (COPD) remain poorly understood. Because clonogenic T cells (CD4(+)CD28(null)) were shown to be increased in autoimmune diseases we hypothesized that CD4(+)CD28(null) T cells play a role in COPD. Here we describe that enhanced presence of CD4(+)CD28(null) cells is associated with impaired lung function. Sixty-four patients and controls were included. T cell phenotype was analysed using flow cytometry. Enzyme-linked immunosorbent assays were utilized to determine cytokines. Statistical evaluations were performed using non-parametric group comparisons and correlations. A logistic regression model was used to determine predictive values of CD4(+)CD28(null) in the diagnosis of COPD. Populations of CD4(+) T cells lacking surface co-stimulatory CD28 were enlarged significantly in evaluated patients when compared with controls. Natural killer (NK)-like T cell receptors (CD94, 158) and intracellular perforin, granzyme B were increased in CD4(+)CD28(null) cells. Cytokine production after triggering of peripheral blood mononuclear cells (PBMCs) was elevated in patients at early disease stages. Receiver operating characteristic curve plotting revealed that presence of CD4(+)CD28(null) T cells has a diagnostic value. These CD4(+)CD28(null) T cells show increased expression of NK-like T cell receptors (CD94, 158) and intracellular perforin and granzyme B. Furthermore, triggering of PBMCs obtained from patients with mild COPD led to increased interferon-gamma and tumour necrosis factor-alpha production in vitro compared with controls. Our finding of increased CD4(+)CD28(null) T cells in COPD indicates that chronic antigen exposure, e.g. through contents of smoke, leads to loss of CD28 and up-regulation of NK cell receptors expression on T cells in susceptible patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220836      PMCID: PMC2669523          DOI: 10.1111/j.1365-2249.2008.03835.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  Natural killer cell activation and inhibition by receptors for MHC class I.

Authors:  M López-Botet; T Bellón
Journal:  Curr Opin Immunol       Date:  1999-06       Impact factor: 7.486

Review 2.  Update in chronic obstructive pulmonary disease 2006.

Authors:  Klaus F Rabe; Bianca Beghé; Fabrizio Luppi; Leonardo M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

3.  Back to the future--defining NK cells and T cells.

Authors:  Lewis L Lanier
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

4.  Severity of airflow limitation is associated with severity of airway inflammation in smokers.

Authors:  A Di Stefano; A Capelli; M Lusuardi; P Balbo; C Vecchio; P Maestrelli; C E Mapp; L M Fabbri; C F Donner; M Saetta
Journal:  Am J Respir Crit Care Med       Date:  1998-10       Impact factor: 21.405

5.  Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis.

Authors:  M Hooper; E G Kallas; D Coffin; D Campbell; T G Evans; R J Looney
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

Review 6.  Systemic effects of chronic obstructive pulmonary disease.

Authors:  Alvar G N Agustí
Journal:  Proc Am Thorac Soc       Date:  2005

7.  Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage.

Authors:  Elisa Pingiotti; Paola Cipriani; Alessandra Marrelli; Vasiliki Liakouli; Simona Fratini; Maria Penco; Roberto Giacomelli
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

Review 8.  Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?

Authors:  Peter M A Calverley; Stephen Scott
Journal:  COPD       Date:  2006-12       Impact factor: 2.409

9.  Increased airway granzyme b and perforin in current and ex-smoking COPD subjects.

Authors:  Sandra Hodge; Greg Hodge; Judith Nairn; Mark Holmes; Paul N Reynolds
Journal:  COPD       Date:  2006-12       Impact factor: 2.409

10.  MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.

Authors:  P F Mercer; J K Shute; A Bhowmik; G C Donaldson; J A Wedzicha; J A Warner
Journal:  Respir Res       Date:  2005-12-22
View more
  22 in total

1.  Serendipity and technical considerations for the measurement of serum heat shock protein HSP27 in patients with COPD and lung cancer.

Authors:  Hendrik Jan Ankersmit; Christopher Lambers; Matthias Zimmermann; Stefan Hacker; Bernhard Moser
Journal:  Cell Stress Chaperones       Date:  2015-08-04       Impact factor: 3.667

2.  Levels of CMV-reactive antibodies correlate with the induction of CD28(null) T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD).

Authors:  Dino B A Tan; Fathiah S Amran; Teck-Hui Teo; Patricia Price; Yuben P Moodley
Journal:  Cell Mol Immunol       Date:  2015-01-26       Impact factor: 11.530

Review 3.  T-cell biology in aging, with a focus on lung disease.

Authors:  Naeun Lee; Min Sun Shin; Insoo Kang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

4.  Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease.

Authors:  G Hodge; V Mukaro; P N Reynolds; S Hodge
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

Review 5.  Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

6.  High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity.

Authors:  K Hoetzenecker; A Mitterbauer; E Guenova; T Schweiger; P Altmann; M Zimmermann; H Hofbauer; L Beer; W Klepetko; H J Ankersmit
Journal:  Wien Klin Wochenschr       Date:  2013-03-27       Impact factor: 1.704

7.  CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.

Authors:  Syed R Gilani; Louis J Vuga; Kathleen O Lindell; Kevin F Gibson; Jianmin Xue; Naftali Kaminski; Vincent G Valentine; Emily K Lindsay; M Patricia George; Chad Steele; Steven R Duncan
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

Review 8.  The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.

Authors:  Gulshan Sharma; Nicola A Hanania; Y Michael Shim
Journal:  Proc Am Thorac Soc       Date:  2009-12-01

Review 9.  Future directions: lung aging, inflammation, and human immunodeficiency virus.

Authors:  Meghan Fitzpatrick; Kristina Crothers; Alison Morris
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

10.  Increased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPD.

Authors:  Stefan Hacker; Christopher Lambers; Andreas Pollreisz; Konrad Hoetzenecker; Michael Lichtenauer; Andreas Mangold; Tina Niederpold; Andreas Hacker; György Lang; Martin Dworschak; Thomas Vukovich; Christopher Gerner; Walter Klepetko; Hendrik Jan Ankersmit
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.